In contrast, acquired truncating mutations in the cytoplasmatic region of the G-CSF receptor do not lead to neutropenia, but rather present a risk factor for the development of leukemia in patients with SCN, most likely due to hyper-responsiveness of selected clones to G-CSF (19, 20). The gene discussed is CSF3R; the disease is neutropenia.